Laura Maria Alcântara

Chroman-4-One Derivatives Targeting Pteridine Reductase 1 and Showing Anti-Parasitic Activity

F. Di Pisa, Giacomo Landi, Lucia Dello Iacono et al. · Molecules · 2017 · 64 citations · Full text

Drug Discovery for Chagas Disease: Impact of Different Host Cell Lines on Assay Performance and Hit Compound Selection

Caio Haddad Franco, Laura Maria Alcântara, Eric Chatelain et al. · Tropical Medicine and Infectious Disease · 2019 · 44 citations · Full text

Microscopy-based phenotypic profiling of infection by Staphylococcus aureus clinical isolates reveals intracellular lifestyle as a prevalent feature

Ines Rodrigues Lopes, Laura Maria Alcântara, Ricardo J. Silva et al. · Nature Communications · 2022 · 41 citations · Full text

Aryl thiosemicarbazones for the treatment of trypanosomatidic infections

Pasquale Linciano, Carolina Borsoi Moraes, Laura Maria Alcântara et al. · European Journal of Medicinal Chemistry · 2018 · 40 citations · Full text

Antiparasitic Agent, Parasitic Protozoa, African Trypanosomiasis +3

Exploiting the 2-Amino-1,3,4-thiadiazole Scaffold To Inhibit <i>Trypanosoma brucei</i> Pteridine Reductase in Support of Early-Stage Drug Discovery

Pasquale Linciano, Alice Dawson, Ina Pöhner et al. · ACS Omega · 2017 · 30 citations · Full text